Oramed gets warrant for 100,000 Scilex shares in exchange for deferred note payment
On February 19, 2026, Oramed entered a Warrant Agreement with Scilex Holding Company. Oramed deferred an amortization payment originally due October 1, 2025 on Scilex's Tranche B Notes, in exchange for a new warrant to buy 100,000 Scilex common shares at an initial exercise price of $20.00 per share. The deferred payment was made to Oramed in November 2025, and the warrant is immediately exercisable.
Key points
- Warrant Agreement with Scilex dated February 19, 2026, with the warrant to buy 100,000 Scilex common shares at an initial $20.00 exercise price
- Warrant expires December 13, 2029 and is immediately exercisable; the exercise price can adjust, with a floor of $8.22 per share
- Deferred amortization payment originally scheduled for October 1, 2025 on the Tranche B Notes was paid in November 2025
- Oramed may not exercise the warrant if that would give it more than 4.99% of Scilex's outstanding common stock, a limit it can raise to no more than 9.99%
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.